Medpace Q2 revenue $469.4M (+27% YoY), EPS $2.35 (+62%); raises FY 2023 guidance

Medpace Holdings, Inc.

2023-Q2 EPS reported $4.20 revenue$894,942,000

Revenue $469.4M (+27.4% YoY), net income $75.6M (+62.5%), diluted EPS $2.35.
Backlog $2.8B (+18.7%); net new business awards $502.3M (+8.3%).
FY 2023 guidance raised: revenue $1.765B-$1.795B, EPS $8.60-$8.97.
Operating cash flow $120.4M, free cash flow $110.3M in H1; $465M cash, no debt.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

Medpace Holdings, Inc. reported financial results for the three and six months ended June 30, 2023.

Period: the three and six months ended June 30, 2023
Result: reported results

Exact text from the filing

On July 24, 2023, Medpace Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2023.

View on SEC.gov

Browse all earnings releases →

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-23-000040

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.